The Analgesic Effect of US guided Erector Spinae Plane Block versus Intrapleural Injection for Thoracoscopic Sympathectomy Surgery in Hyperhidrosis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202606834207461

Enrollment

116

Registered

2026-06-29

Start date

2024-11-05

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genetic Diseases Surgery Anaesthesia

Interventions

erector spinae plane block

intrapleural injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Patients aged between 21-40 years of either sex - with American Society of Anesthesiologists physical status (ASA) I & II scheduled for thoracoscopic sympathectomy

Exclusion criteria

Exclusion criteria: -The research excluded patients with coagulopathies, - local infections - neuropathies, neuromuscular diseases - mental illnesses - a history of thoracic surgery. -Patients who had a history of local anesthetic allergies, were on chronic pain medications, were drug users - refused treatment were also eliminated

Design outcomes

Primary

Measure	Time frame
the total analgesic consumption in the first 24 h postoperative	—

Secondary

Measure	Time frame
postoperative severity of the pain assessed by visual analogue scale (0-100), the time for 1st request of analgesia and assosciated side effects and complication if present as secondary outcome.	—

Countries

Egypt

Contacts

Public Contactmostafa tawfeek

puplic contact

mostafaessam234567@gmail.com+201028475770

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026